Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Comparing consultative versus collaborative ways patients, clinicians, and the public partner with health teams.

Official title: Participatory Approach to Qualitative Research (PAQ): Comparing Two Methods of Engaging Stakeholders in Qualitative Research

Run by Dartmouth-Hitchcock Medical Center · NCT06838689 · Data updated 2026-11-12

This project will test whether a consultative or a collaborative way of involving patients, care partners, clinicians, and community members leads to better engagement and trust when they work with research teams on qualitative projects about pediatric mental health, cancer screening, and serious illness.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment136 (estimated)
SponsorDartmouth-Hitchcock Medical Center
Academic / other
Locations2 sites (Hanover, New Hampshire and 1 other locations)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedAugust 30, 2027
Study endsOctober 31, 2027
Registry record updatedNovember 19, 2025
Trial IDNCT06838689 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults who can communicate in English, are able to use a computer or smartphone, and who have lived experience or professional roles relevant to pediatric mental health, cancer screening, or serious illness (including patients, care partners, clinicians, teachers, and community members) are ideal candidates.

Probably not a fit

Children below the age thresholds, people who cannot communicate in English, those unable to provide consent or to use a computer or smartphone, and prisoners are not eligible and unlikely to receive benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a stratified randomized trial that assigns patient, public, and clinician involvement (PPCI) participants to either a Consultative or a Collaborative approach while they work on one of three real qualitative interview projects (pediatric mental health, cancer screening, or serious illness). Participants will be engaged across study stages including design, data collection, analysis, and dissemination using detailed guides for each PPCI approach. The trial measures partner-reported outcomes such as engagement, trust, and patient-centeredness of the research. The investigators hypothesize the Collaborative approach will yield higher engagement, trust, and patient-centeredness, particularly among historically underrepresented groups.

Why it matters

Potential benefit: If successful, the findings could make health research more patient-centered and trustworthy so study results better reflect the needs and experiences of diverse communities.

How similar studies have gone: According to the investigators, this appears to be the first randomized trial comparing PPCI approaches, with prior support coming mainly from theory and observational or non-randomized work.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria \& Exclusion criteria across three sub-specialties:

Pediatric mental health

Inclusion:

* Adults aged ≥18 years
* Can communicate in English
* Able to take part in research activities via a computer or a smartphone
* Patients, care partners, clinicians, other healthcare professionals, teachers and school staff, health policy experts, and community members
* Has lived experience or professional expertise relating to pediatric mental health

Exclusion:

* Children \<18 years
* Cannot communicate in English
* Adults unable to provide verbal consent
* Prisoners
* Unable to take part in research activities via a computer or a smartphone

Generalized cancer screening

Inclusion:

* Adults aged ≥21 years
* Can communicate in English
* Able to take part in research activities via a computer or a smartphone
* Patients, care partners, clinicians, other healthcare professionals, health policy experts, and community members
* Is eligible for population-based cancer screening tests (breast, prostate, cervical, colorectal cancer), or has lived experience or professional expertise relating to generalized cancer screening

Exclusion:

* Children \<18 years
* Cannot communicate in English
* Adults unable to provide verbal consent
* Prisoners
* Unable to take part in research activities via a computer or a smartphone

Serious illness experience

Inclusion:

* Adults aged ≥18 years
* Can communicate in English
* Able to take part in research activities via a computer or a smartphone
* Patients, care partners, clinicians, other healthcare professionals, health policy experts, and community members
* Has lived experience or professional expertise relating to serious illness (defined as "a health condition that carries a high risk of mortality and either negatively impacts a person's daily functioning or quality of life or excessively strains his or her caregivers."

Exclusion:

* Children \<18 years
* Cannot communicate in English
* Adults unable to provide verbal consent
* Prisoners
* Unable to take part in research activities via a computer or a smartphone

Note: We will not specifically exclude pregnant women, so they may be included incidentally.

Where it's running

  • Geisel School of Medicine at Dartmouth
    Hanover, New Hampshire, United States
    Recruiting
  • Dartmouth-Hitchcock Medical Center
    Lebanon, New Hampshire, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.